BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26228884)

  • 1. Early Quantification of Hematoma Hounsfield Units on Noncontrast CT in Acute Intraventricular Hemorrhage Predicts Ventricular Clearance after Intraventricular Thrombolysis.
    Kornbluth J; Nekoovaght-Tak S; Ullman N; Carhuapoma JR; Hanley DF; Ziai W
    AJNR Am J Neuroradiol; 2015 Sep; 36(9):1609-15. PubMed ID: 26228884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Volumetric Change of Intracerebral Hemorrhage in Patients Treated with Thrombolysis for Intraventricular Hemorrhage.
    Staub-Bartelt F; van Lieshout JH; Beez T; Kram R; Hänggi D; Beseoglu K
    Neurocrit Care; 2021 Apr; 34(2):529-536. PubMed ID: 32737761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No exacerbation of perihematomal edema with intraventricular tissue plasminogen activator in patients with spontaneous intraventricular hemorrhage.
    Ziai W; Moullaali T; Nekoovaght-Tak S; Ullman N; Brooks JS; Morgan TC; Hanley DF
    Neurocrit Care; 2013 Jun; 18(3):354-61. PubMed ID: 23463422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter, randomized, double-blinded, placebo-controlled phase III study of Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III).
    Ziai WC; Tuhrim S; Lane K; McBee N; Lees K; Dawson J; Butcher K; Vespa P; Wright DW; Keyl PM; Mendelow AD; Kase C; Wijman C; Lapointe M; John S; Thompson R; Thompson C; Mayo S; Reilly P; Janis S; Awad I; Hanley DF;
    Int J Stroke; 2014 Jun; 9(4):536-42. PubMed ID: 24033910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial.
    Naff N; Williams MA; Keyl PM; Tuhrim S; Bullock MR; Mayer SA; Coplin W; Narayan R; Haines S; Cruz-Flores S; Zuccarello M; Brock D; Awad I; Ziai WC; Marmarou A; Rhoney D; McBee N; Lane K; Hanley DF
    Stroke; 2011 Nov; 42(11):3009-16. PubMed ID: 21868730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolution of intraventricular hemorrhage varies by ventricular region and dose of intraventricular thrombolytic: the Clot Lysis: Evaluating Accelerated Resolution of IVH (CLEAR IVH) program.
    Webb AJ; Ullman NL; Mann S; Muschelli J; Awad IA; Hanley DF
    Stroke; 2012 Jun; 43(6):1666-8. PubMed ID: 22474059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Intraventricular Alteplase Use and Parenchymal Hematoma Volume in Patients With Spontaneous Intracerebral Hemorrhage and Intraventricular Hemorrhage.
    Witsch J; Roh DJ; Avadhani R; Merkler AE; Kamel H; Awad I; Hanley DF; Ziai WC; Murthy SB
    JAMA Netw Open; 2021 Dec; 4(12):e2135773. PubMed ID: 34860246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteplase (rtPA) treatment of intraventricular hematoma (IVH): safety of an efficient methodological approach for rapid clot removal.
    Bartek J; Hansen-Schwartz J; Bergdal O; Degn J; Romner B; Welling KL; Fischer W
    Acta Neurochir Suppl; 2011; 111():409-13. PubMed ID: 21725792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting clot lysis rates in patients with spontaneous intraventricular hemorrhage.
    Ziai WC; Muschelli J; Thompson CB; Keyl PM; Lane K; Shao S; Hanley DF
    Stroke; 2012 May; 43(5):1234-9. PubMed ID: 22382155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fibrinolysis of intraventricular hematoma with rt-PA].
    Schwarz S; Schwab S; Steiner HH; Hanley D; Hacke W
    Nervenarzt; 1999 Feb; 70(2):123-30. PubMed ID: 10098147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic aspiration-thrombolysis of intracerebral hemorrhage and its impact on perihematoma brain edema.
    Carhuapoma JR; Barrett RJ; Keyl PM; Hanley DF; Johnson RR
    Neurocrit Care; 2008; 8(3):322-9. PubMed ID: 18327659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of thrombus hounsfield units on noncontrast CT predicts stroke subtype and early recanalization after intravenous recombinant tissue plasminogen activator.
    Puig J; Pedraza S; Demchuk A; Daunis-I-Estadella J; Termes H; Blasco G; Soria G; Boada I; Remollo S; Baños J; Serena J; Castellanos M
    AJNR Am J Neuroradiol; 2012 Jan; 33(1):90-6. PubMed ID: 22158924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraventricular recombinant tissue plasminogen activator for lysis of intraventricular haemorrhage.
    Rohde V; Schaller C; Hassler WE
    J Neurol Neurosurg Psychiatry; 1995 Apr; 58(4):447-51. PubMed ID: 7738552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of delayed edema formation after fibrinolytic therapy for intracerebral hematomas: preliminary experimental data.
    Rohde V; Uzma N; Thiex R; Samadani U
    Acta Neurochir Suppl; 2008; 105():101-4. PubMed ID: 19066092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catheter placement for lysis of spontaneous intracerebral hematomas: does a catheter position in the core of the hematoma allow more effective and faster hematoma lysis?
    Malinova V; Schlegel A; Rohde V; Mielke D
    Neurosurg Rev; 2017 Jul; 40(3):397-402. PubMed ID: 27726038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of irrigation on fibrinolytic rtPA therapy in a clot model of intracerebral haemorrhage: a systematic in vitro study.
    Masomi-Bornwassser J; Freguia F; Müller-Werkmeister H; Kempski O; Giese A; Keric N
    Acta Neurochir (Wien); 2018 Jun; 160(6):1159-1165. PubMed ID: 29564653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of intraventricular hemorrhage with intraventricular administration of recombinant tissue plasminogen activator A clinical study of 18 cases.
    Vereecken KK; Van Havenbergh T; De Beuckelaar W; Parizel PM; Jorens PG
    Clin Neurol Neurosurg; 2006 Jul; 108(5):451-5. PubMed ID: 16139422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrahematomal catheter placement with connection to the ventricular system allows more effective thrombolysis of combined intracerebral and intraventricular hematomas.
    Iliev B; Schlegel A; Mielke D; Rohde V; Malinova V
    Neurosurg Rev; 2020 Dec; 43(6):1531-1537. PubMed ID: 31612335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary findings of the minimally-invasive surgery plus rtPA for intracerebral hemorrhage evacuation (MISTIE) clinical trial.
    Morgan T; Zuccarello M; Narayan R; Keyl P; Lane K; Hanley D
    Acta Neurochir Suppl; 2008; 105():147-51. PubMed ID: 19066101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O2L-001, an innovative thrombolytic to evacuate intracerebral haematoma.
    Thiebaut AM; Louet ER; Ianszen M; Guichard MJ; Hanley DF; Gaudin C; Parcq J
    Brain; 2023 Nov; 146(11):4690-4701. PubMed ID: 37450572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.